Clinical trial
Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder
NCT00183430 · Seattle Institute for Biomedical and Clinical Research, Other · Terminated
Key facts
| NCT number | NCT00183430 |
|---|---|
| Title | Prazosin for Treating Noncombat Trauma Post-Traumatic Stress Disorder |
| Official title | Prazosin for Noncombat Trauma PTSD |
| Lead sponsor | Seattle Institute for Biomedical and Clinical Research, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Post-Traumatic Stress Disorder, Sleep Initiation and Maintenance Disorders |
| Intervention type | Behavioral, Drug |
| Interventions | Prazosin, Placebo, Psychotherapy |
| Enrollment | 20 |
| Start date | Oct 1, 2003 |
| Primary completion | May 1, 2009 |
| Completion | Dec 1, 2010 |
| First posted | Sep 16, 2005 |
| Last update posted | Jun 14, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: